Rapid Micro Biosystems, Inc. Class A Common Stock
RPID US75340L1044
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -50% | -90% | -39% | -1% | 5% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Spignesi Robert G. Jr. CEO |
3.32 USD |
11,881 Sold |
39,481 USD |
11/07/2025 | 14/07/2025 |
| Spignesi Robert G. Jr. CEO |
3.33 USD |
11,874 Sold |
39,499 USD |
11/07/2025 | 11/07/2025 |
| Spignesi Robert G. Jr. CEO |
3.40 USD |
11,617 Sold |
39,475 USD |
08/07/2025 | 10/07/2025 |
| Spignesi Robert G. Jr. CEO |
3.51 USD |
11,247 Sold |
39,480 USD |
08/07/2025 | 09/07/2025 |
| Spignesi Robert G. Jr. CEO |
3.51 USD |
10,824 Sold |
38,021 USD |
08/07/2025 | 08/07/2025 |
| Pei Melinda Litherland |
1.04 USD |
9,120 Bought |
9,484 USD |
03/12/2024 | 05/12/2024 |
| Pei Melinda Litherland |
1.00 USD |
10,880 Bought |
10,880 USD |
03/12/2024 | 03/12/2024 |
| Pei Melinda Litherland |
1.05 USD |
19,892 Bought |
20,887 USD |
26/11/2024 | 27/11/2024 |
| Pei Melinda Litherland |
1.04 USD |
108 Bought |
112 USD |
26/11/2024 | 26/11/2024 |
| Malloy Kirk |
0.91 USD |
50,000 Bought |
45,335 USD |
08/08/2024 | 08/08/2024 |